Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial

Cardiol J. 2022;29(1):148-153. doi: 10.5603/CJ.a2021.0118. Epub 2021 Oct 8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Coronary Syndrome* / diagnosis
  • Acute Coronary Syndrome* / drug therapy
  • Aspirin / adverse effects
  • Carbidopa
  • Drug Combinations
  • Humans
  • Levodopa / analogs & derivatives
  • Percutaneous Coronary Intervention*
  • Platelet Aggregation Inhibitors / adverse effects
  • Ticagrelor
  • Treatment Outcome

Substances

  • Drug Combinations
  • Platelet Aggregation Inhibitors
  • sirio
  • Levodopa
  • Ticagrelor
  • Carbidopa
  • Aspirin